Medifast
Stock Forecast, Prediction & Price Target
Medifast (MED) stock Price Target by analysts
$17
Potential upside: 20.14%
Medifast price prediction
What is Medifast stock analysts` prediction?
Medifast stock forecast: Based on 1 Wall Street analysts` predicted price targets for Medifast in the last 3 months, the avarage price target is $17, with a high forecast of $NaN. The average price target represents a 20.14% change from the last price of $14.15.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Medifast stock Price Target by analysts
Full breakdown of analysts given Medifast price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Linda Bolton Weiser D.A. Davidson | 50% 2/4 | 10 months ago | $17 20.14% upside | $20.4 | StreetInsider | Previous targets (3) |
Linda Bolton Weiser D.A. Davidson | 50% 2/4 | over 1 year ago | $17.5 23.67% upside | $23.97 | StreetInsider | Previous targets (3) |
Linda Bolton Weiser D.A. Davidson | 50% 2/4 | over 1 year ago | $25 76.67% upside | $35.51 | StreetInsider | Previous targets (3) |
Stephanie Wissink Jefferies | 0% 0/1 | over 2 years ago | $150 960.07% upside | $81.22 | Benzinga | Previous targets (0) |
Linda Bolton Weiser D.A. Davidson | 50% 2/4 | over 2 years ago | $94 564.31% upside | $96.39 | Benzinga | Previous targets (3) |
Medifast Financial Estimates
Medifast Revenue Estimates
Medifast EBITDA Estimates
Medifast Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $1.52B N/A | $1.59B 4.75% | $1.07B -32.93% | Avg: $655.35M Low: $641.35M High: $669.34M avg. -38.86% | |||
Net Income
% change YoY
| $164.03M N/A | $143.56M -12.47% | $99.41M -30.75% | Avg: $17.15M Low: $16.70M High: $17.47M avg. -82.74% | |||
EBITDA
% change YoY
| $223.05M N/A | $195.78M -12.22% | $139.50M -28.74% | Avg: $87.79M Low: $85.92M High: $89.67M avg. -37.06% | |||
EPS
% change YoY
| $14.01 N/A | $12.82 -8.49% | $9.13 -28.78% | Avg: $1.57 Low: $1.53 High: $1.6 avg. -82.85% | |||
Operating Expenses
% change YoY
| $911.35M N/A | $955.60M 4.85% | $649.44M -32.03% | Avg: $396.93M Low: $388.45M High: $405.40M avg. -38.88% | |||
FAQ
What is Medifast stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -82.74% in 2025-2025.
We have gathered data from 2 analysts. Their low estimate is 16.70M, average is 17.15M and high is 17.47M.
What is Medifast stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -38.86% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $641.35M, average is $655.35M and high is $669.34M.
What is Medifast stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -82.85% in 2025-2025.
We have gathered data from 2 analysts. Their low earnings per share estimate is $1.53, average is $1.57 and high is $1.6.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Medifast stock. The most successful analyst is Linda Bolton Weiser whose win rate is 50%. He has correctly predicted 2/4 price targets.